|
31 |
Drei-Jahres-Follow-Up-Erhebung einer dreiwöchigen Open-label Placebo-Behandlung bei Patienten mit chronischen Rückenschmerzen
Duisburg-Essen, 2025
|
|
|
32 |
Impact of a dietary supplementation with French maritime pine bark extract Pycnogenol® on salivary and serum inflammatory biomarkers during non-surgical periodontal therapy — A randomized placebo-controlled double-blind trial
Bayer, Jasmin. - Würzburg : Universität Würzburg, 2025
|
|
|
|
33 |
Intermittent theta burst stimulation of the left dorsolateral prefrontal cortex has no additional effect on the efficacy of virtual reality exposure therapy for acrophobia. A randomized double-blind placebo-controlled study
Bohmeier, Barbara. - Würzburg : Universität Würzburg, 2025
|
|
|
|
34 |
Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis
Murase, Jenny E.. - Freiburg : Universität, 2025
|
|
|
|
35 |
Measuring the effect of short, animated storytelling videos to boost psychological capital in US adults: a randomized controlled trial
Adam, Maya. - Freiburg : Universität, 2025
|
|
|
|
36 |
Meditation, psychedelics, and brain connectivity: a randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat
Egger, Klemens. - Freiburg : Universität, 2025
|
|
|
|
37 |
Methoden zur Förderung von Placeboeffekten in der Physiotherapie bei Patient*innen mit Spannungskopfschmerz : eine Handlungsempfehlung für die Praxis
Röder, Franziska. - Hildesheim : HAWK, Hochschule für angewandte Wissenschaft und Kunst Hildesheim/Holzminden/Göttingen - Bibliothek, 2025
|
|
|
|
38 |
Minimal couple intervention to improve psychobiological stress resilience
Aguilar-Raab, Corina. - Freiburg : Universität, 2025
|
|
|
|
39 |
Modelling the effects of treatment expectations on reward learning
Augustat, Nick. - Marburg, 2025
|
|
|
|
40 |
Octreotide subcutaneous depot for acromegaly: a randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1
Ferone, Diego. - Freiburg : Universität, 2025
|
|
Administration
